landiolol has been researched along with Tachycardia, Supraventricular in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, Y; Hasegawa, S; Segawa, T; Yamamoto, S | 1 |
| Syed, YY | 1 |
| Adachi, T; Aonuma, K; Baba, M; Hasegawa, T; Hiraya, D; Hoshi, T; Kuroki, K; Sato, A | 1 |
| Kikawa, S; Taenaka, N | 1 |
| Deng, X; Guo, Q; He, J; He, P; Lang, Z; Li, S; Tao, G; Wang, X; Xiao, J; Xue, Z; Yang, T; Zhao, Y; Zou, Q | 1 |
| Fujita, Y; Miyake, K; Miyazu, M; Sento, Y; Sobue, K; Tomita, M; Yoshimura, S; Yoshizawa, S | 1 |
| Hakone, M; Kasuya, Y; Motoyasu, A; Yamada, T; Yorozu, T | 1 |
| Kasuya, S; Kikuchi, C; Saito, N; Tanaka, S | 1 |
| Ibe, T; Kamiyoshihara, M; Kawashima, O; Nagashima, T; Nakano, T; Shimizu, K; Takeyoshi, I | 1 |
| Hirai, H; Hosono, M; Morisaki, A; Nakahira, A; Sakaguchi, M; Sasaki, Y; Seo, H; Suehiro, S | 1 |
| Azami, T; Hirate, H; Ito, H; Katsuya, H; Sasano, H; So, M; Sobue, K; Sugiura, T | 1 |
| Atarashi, H; Endoh, Y; Hayakawa, H; Ino, T; Kuruma, A; Saitoh, H; Yashima, M | 1 |
1 review(s) available for landiolol and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Landiolol: A Review in Tachyarrhythmias.
Topics: Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Approval; Heart Failure; Heart Rate; Humans; Japan; Morpholines; Tachycardia; Tachycardia, Supraventricular; Treatment Outcome; Urea; Ventricular Dysfunction, Left | 2018 |
3 trial(s) available for landiolol and Tachycardia, Supraventricular
| Article | Year |
|---|---|
The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Morpholines; Postoperative Complications; Prospective Studies; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2013 |
Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Morpholines; Propanolamines; Tachycardia, Supraventricular; Treatment Outcome; Urea; Young Adult | 2015 |
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Tachycardia, Ventricular; Urea; Ventricular Premature Complexes | 2000 |
8 other study(ies) available for landiolol and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Landiolol is effective for the treatment of tachycardia-induced cardiogenic shock in patients during septic shock therapy.
Topics: Aged; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Humans; Morpholines; Shock, Cardiogenic; Shock, Septic; Tachycardia, Supraventricular; Urea | 2017 |
Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Atrial Fibrillation; Blood Pressure; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Urea | 2014 |
Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study.
Topics: Blood Pressure; Child; Child, Preschool; Cohort Studies; Female; Fontan Procedure; Heart Rate; Humans; Male; Morpholines; Postoperative Period; Pulmonary Artery; Retrospective Studies; Tachycardia; Tachycardia, Supraventricular; Urea | 2016 |
[Anesthetic Management of a Patient who Developed Intraoperative Paroxysmal Supraventricular Tachycardia with Pulseless Electric Activity].
Topics: Adrenergic beta-Antagonists; Aged; Anesthetics; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Arrest; Humans; Intraoperative Complications; Morpholines; Postoperative Period; Preoperative Care; Tachycardia, Supraventricular; Urea | 2016 |
[Clinical evaluation of landiolol hydrochloride, an ultra short-acting beta-blocker].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Tachycardia, Supraventricular; Urea | 2008 |
Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Female; Heart Rate; Humans; Infusions, Intravenous; Lung Diseases; Male; Middle Aged; Morpholines; Retrospective Studies; Secondary Prevention; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2012 |
Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function.
Topics: Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Female; Heart Diseases; Heart Rate; Heart Valve Prosthesis Implantation; Humans; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Male; Middle Aged; Mitral Valve Annuloplasty; Morpholines; Stroke Volume; Tachycardia, Supraventricular; Treatment Outcome; Urea; Ventricular Function, Left | 2012 |
Use of landiolol in the perioperative management of supraventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Dopamine; Ebstein Anomaly; Electric Countershock; Female; Heart Rate; Humans; Hypotension; Middle Aged; Morpholines; Perioperative Care; Postoperative Complications; Tachycardia, Supraventricular; Treatment Outcome; Urea | 2006 |